The President had Regeneron and Gilead stock

0
760


Kelly Tyko

| USA TODAY

President Donald Trump previously reported that he won capital gains from Regeneron Pharmaceuticals and Gilead Sciences Inc., the makers of two of the drugs he took as part of his COVID-19 treatment plan.



LEAVE A REPLY

Please enter your comment!
Please enter your name here